To explore the mechanism underlying CTSL accumulation in HNSCC, we treated FaDu and HN8 cells with the proteasome inhibitor MG132 or the lysosomal inhibitor chloroquine (CQ). The gene discussed is CTSL; the disease is head and neck squamous cell carcinoma.